Works matching IS 00015792 AND DT 2022 AND VI 145 AND IP 5
Results: 14
Front & Back Matter.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 1, doi. 10.1159/000527135
- Publication type:
- Article
PharmaNews.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 572, doi. 10.1159/000526949
- Publication type:
- Article
Dramatic Recovery after Etoposide Phosphate Infusion for Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome following Treatment with Tisagenlecleucel in a Young Patient with Relapsed Acute Lymphoblastic Leukemia: A Case Report.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 537, doi. 10.1159/000525576
- By:
- Publication type:
- Article
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating Mutations.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 529, doi. 10.1159/000525566
- By:
- Publication type:
- Article
Successful Treatment of the TEMPI Syndrome with Pomalidomide Plus Dexamethasone Followed by Autologous Stem Cell Transplantation.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 553, doi. 10.1159/000525056
- By:
- Publication type:
- Article
Tanshinone IIA Inhibits Tissue Factor Expression Induced by Thrombin in Human Umbilical Vein Endothelial Cells via PAR-1 and p38 MAPK Signaling Pathway.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 517, doi. 10.1159/000525055
- By:
- Publication type:
- Article
Gilteritinib in Isolated Breast Relapse of FLT3 Positive Acute Myeloid Leukemia: A Case Report and Review of Literature.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 566, doi. 10.1159/000524878
- By:
- Publication type:
- Article
Small RNA Sequencing Reveals Exosomal miRNAs as Unique Feature Markers in Unprovoked Venous Thromboembolism.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 505, doi. 10.1159/000524569
- By:
- Publication type:
- Article
Association between P-Selectin Autoantibody Positive and Response to Steroid Treatment in Newly Diagnosed Immune Thrombocytopenia Patients.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 499, doi. 10.1159/000524535
- By:
- Publication type:
- Article
Myeloid Neoplasm with PCM1-PDGFRB Transcript Responded to Low-Dose Imatinib: One Case Report with Literature Review.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 560, doi. 10.1159/000524275
- By:
- Publication type:
- Article
MiR-199a-3p Overexpression Suppressed Cell Proliferation and Sensitized Chronic Myeloid Leukaemia Cells to Imatinib by Inhibiting mTOR Signalling.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 484, doi. 10.1159/000524158
- By:
- Publication type:
- Article
Long-Term Adherence to Direct Oral Anticoagulants in Patients with Atrial Fibrillation: A Comparative Cross-Sectional Study.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 476, doi. 10.1159/000524094
- By:
- Publication type:
- Article
Expression of Programmed Cell Death-1 and Programmed Cell Death Ligands in Nodal Peripheral T-Cell Lymphoma: Expression Pattern and Potential Prognostic Relevance.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 542, doi. 10.1159/000523873
- By:
- Publication type:
- Article
Splenectomy Outcomes in Relapsed or Refractory Immune Thrombocytopenia according to First-Line Intravenous Immunoglobulin Response.
- Published in:
- Acta Haematologica, 2022, v. 145, n. 5, p. 465, doi. 10.1159/000521912
- By:
- Publication type:
- Article